CATALYST PHARMACEUTICALS INC. - COMMON STOCK

Catalyst Pharmaceuticals to Participate at the Barclays 26th Annual Global Healthcare Conference

05 мар 2024 07:03:00 Источник Nasdaq GlobeNewswire

Catalyst Pharmaceuticals Reports Strong Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update

28 фев 2024 17:03:23 Источник Nasdaq GlobeNewswire

Catalyst Pharmaceuticals to Present at MDA Clinical & Scientific Conference Details of Registry for Study of Long-Term Safety and Quality of Life in Duchenne Muscular Dystrophy Patients Treated with AGAMREE

27 фев 2024 07:03:00 Источник Nasdaq GlobeNewswire

Catalyst Pharmaceuticals Announces Publication of Santhera Pharmaceutical’s VISION-DMD Vamorolone (AGAMREE®) Study Results in the Peer-Reviewed Journal Neurology

21 фев 2024 08:00:00 Источник Nasdaq GlobeNewswire

Catalyst Pharmaceuticals to Report Fourth Quarter and Full-Year 2023 Financial Results on February 28, 2024

14 фев 2024 07:03:00 Источник Nasdaq GlobeNewswire

Catalyst Pharmaceuticals, Inc. Announces Closing of Public Offering

09 янв 2024 15:05:13 Источник Nasdaq GlobeNewswire

Catalyst Pharmaceuticals, Inc. Announces Pricing of Public Offering of Common Stock

05 янв 2024 07:02:06 Источник Nasdaq GlobeNewswire

Catalyst Pharmaceuticals, Inc. Announces Proposed Public Offering of Common Stock

04 янв 2024 15:49:58 Источник Nasdaq GlobeNewswire

Catalyst Pharmaceuticals Announces FIRDAPSE® New Drug Application Submitted in Japan by Partner DyDo Pharma

18 дек 2023 05:30:03 Источник Nasdaq GlobeNewswire

Catalyst Pharmaceuticals Receives Prestigious Ranking on Forbes 2024 List of America's Most Successful Small-Cap Companies

05 дек 2023 07:03:00 Источник Nasdaq GlobeNewswire

Catalyst Pharmaceuticals Announces Appointment of Michael W. Kalb as Chief Financial Officer and Other Executive Promotions

04 дек 2023 07:03:00 Источник Nasdaq GlobeNewswire

Catalyst Pharmaceuticals To Participate in Piper Sandler 35th Annual Healthcare Conference

16 ноя 2023 07:05:00 Источник Nasdaq GlobeNewswire

Catalyst Pharmaceuticals Reports Strong Third Quarter 2023 Financial Results and Corporate Update

08 ноя 2023 15:11:02 Источник Nasdaq GlobeNewswire

Catalyst Pharmaceuticals Receives Two New U.S. Patent Allowances For FIRDAPSE®

02 ноя 2023 09:37:31 Источник Nasdaq GlobeNewswire

Catalyst Pharmaceuticals Partners with Sofie's Journey to Bring Focus on Epilepsy at the 11th Annual Epilepsy Awareness and Education Expo

30 окт 2023 07:03:00 Источник Nasdaq GlobeNewswire

Catalyst Pharmaceuticals Reports FDA Approval of AGAMREE® (vamorolone) for Duchenne Muscular Dystrophy Granted to Santhera Pharmaceuticals

26 окт 2023 14:19:11 Источник Nasdaq GlobeNewswire

Catalyst Pharmaceuticals to Report Third Quarter 2023 Financial Results on November 8, 2023

23 окт 2023 07:03:00 Источник Nasdaq GlobeNewswire

Catalyst Pharmaceuticals Appoints Richard J. Daly as Chief Executive Officer

19 окт 2023 07:03:00 Источник Nasdaq GlobeNewswire

Patrick J. McEnany, Chairman and CEO of Catalyst Pharmaceuticals, Receives Prestigious 2023 Lifetime Achievement Award from BioFlorida

16 окт 2023 07:03:00 Источник Nasdaq GlobeNewswire

Catalyst Pharmaceuticals Announces FDA Acceptance of the Supplemental New Drug Application for FIRDAPSE®

13 окт 2023 07:03:00 Источник Nasdaq GlobeNewswire